Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avalglucosidase Alfa vs Alglucosidase Alfa in Late-onset Pompe Disease
NCT02782741Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2016
- Primary completion
- Mar 2020
- Modality
- Replacement Enzymes
- Countries
- 25
01
Overview
A Phase 3 trial of avalglucosidase alfa in Pompe disease, sponsored by Sanofi. Started Nov 2016; status: completed.
02
Drugs
avalglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT02782741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782741.